ABVX vs SOLV: fair value comparison
ABIVAX Société Anonyme and Solventum Corporation · Updated 2026-10-19
ABVX reports in EUR, so no same-currency fair-value verdict is published for it. Within Healthcare, SOLV currently ranks higher by quality score.
| ABVX | SOLV | |
|---|---|---|
| Verdict | Awaiting full valuation | Fairly valued |
| Last price | $95.10 | $87.29 |
| 12-month range | $72.50–$145.31 | $62.49–$92.44 |
| Rank by discount to fair value | — | #63 of 108 Healthcare |
| Rank by quality score | #215 of 301 Healthcare | #214 of 301 Healthcare |
| Quality grade | F | F |
| Leverage | Low | Moderate |
| Margin trend | Expanding | Stable |
| Revenue growth | Declining | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Downtrend | — |
| 52-week position | The lower-middle quarter | The top quarter |
Full single-stock breakdowns: ABVX fair value analysis · SOLV fair value analysis